Article
Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Cancer biology & therapy - 1 Jan 2015
Miura John T, Xiu Joanne, Thomas James, George Ben, Carron Benjamin R, Tsai Susan, Johnston Fabian M, Turaga Kiran K, Gamblin T Clark
Abstract excerpt
BACKGROUND: NCCN states that chemotherapies for advanced esophageal and gastric cancers may be used interchangeably. Biomarkers from gastroesophageal cancer patients were interrogated to identify actionable alterations with therapeutic implications. METHODS: 666 gastric and 640 esophageal cancer cases referred to Caris Life Sciences between 2009 thru 2013 were evaluated. Specific testing was performed, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
